Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jesse Jones

Diagnostic Radiology Birmingham, AL Medical Doctor

NPI 1497027387 CMS profile 1398326

619 19Th St S, Birmingham, AL 35249

Open in the dashboard

General payments

$161,079

525 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$332,596 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Jesse Jones of Birmingham, AL is reported in the CMS Open Payments database as having received $161,079 across 525 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $332,596 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,877 102
2024 General $29,631 108
2023 General $27,501 80
2022 General $40,905 109
2021 General $21,968 65
2020 General $5,776 34
2019 General $3,421 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jesse Jones
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Jesse Jones were reported at $31,877. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Jesse Jones Diagnostic Radiology median Middle half National median
2019 $3,421 $108 $29–$318 $163
2020 $5,776 $65 $21–$252 $114
2021 $21,968 $92 $24–$292 $132
2022 $40,905 $104 $29–$294 $149
2023 $27,501 $110 $29–$337 $160
2024 $29,631 $113 $30–$356 $164
2025 $31,877 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $122,319 149 payments
  2. DePuy Synthes Sales Inc. $8,110 154 payments
  3. DePuy Synthes Products, Inc. $5,682 4 payments
  4. MicroVention, Inc. $5,086 58 payments
  5. MIVI Neuroscience, Inc. $4,197 6 payments
  6. Stryker Corporation $4,011 40 payments
  7. Scientia Vascular $3,866 13 payments
  8. Balt USA, LLC $2,845 22 payments
  9. Siemens Medical Solutions USA, Inc. $1,020 6 payments
  10. Medtronic USA, Inc. $861 16 payments
  11. Other $3,083 57 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $104,324 39 payments
  2. Travel and Lodging $32,765 74 payments
  3. Food and Beverage $23,983 410 payments
  4. Gift $8 2 payments
Products named General payments · program years 2019–2025
  1. EMBOGUARD $61,012 57 payments
  2. TRUFILL Neurovascular $55,575 100 payments
  3. Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device $52,149 68 payments
  4. CEREPAK UNIFORM $19,895 67 payments
  5. EMBOTRAP $18,429 64 payments
  6. Spotlight $5,664 3 payments
  7. WEB ANEURYSM EMBOLIZATION SYSTEM $2,444 33 payments
  8. TRUFILL Neurovascular $2,275 5 payments
  9. STENT $2,230 20 payments
  10. SURPASS EVOLVE $2,056 12 payments
  11. Other $32,636 326 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

37

Median for Diagnostic Radiology: 24

Drug cost

$6,476

Median for Diagnostic Radiology: $190

Branded share of claims

70.3%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Brilinta Ticagrelor Brand 11 $6,100
Doxycycline Monohydrate Generic 11 $250
Clopidogrel Clopidogrel Bisulfate Brand 15 $126

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 79 billing codes

Paid by Medicare

$64,163

Medicare's payments for the services billed

Medicare patients

150

Average age 70

Services billed

552

73 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Diabetes 39%
Depression 39%
Ischemic heart disease 36%
Chronic kidney disease 36%
Heart failure 28%
Atrial fibrillation 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

525 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record